Novartis AG (MEX:NVS N) Moat Score : 8/10 (As of Jul. 10, 2025)

View and export this data going back to 2008. Start your Free Trial

What is Novartis AG Moat Score?

Novartis AG has the Moat Score of 8, which implies that the company might have Wide Moat - Clear and robust wide moat.

Novartis AG has Wide Moat: Novartis AG has a robust portfolio of patents, strong brand strength, and significant regulatory barriers. The company benefits from economies of scale, a superior distribution network, and consistent innovation, resulting in a clear and robust wide moat.

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes Novartis AG might have Wide Moat - Clear and robust wide moat.

Competitive Comparison of Novartis AG's Moat Score

For the Drug Manufacturers - General subindustry, Novartis AG's Moat Score, along with its competitors' market caps and Moat Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Novartis AG's Moat Score Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Novartis AG's Moat Score distribution charts can be found below:

* The bar in red indicates where Novartis AG's Moat Score falls into.

Save Embed

;

Save Embed

;

Novartis AG (MEX:NVS N) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score	Moat Level
10	Wide Moat - Exceptionally dominant and durable wide moat
8 - 9	Wide Moat - Clear and robust wide moat
7	Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6	Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5	Narrow Moat - Solid narrow moat
4	Narrow Moat - Discernible but modest moat
1 - 3	No Moat - Very weak/transient advantages
0	No Moat - No discernible moat

Novartis AG Moat Score Related Terms

Thank you for viewing the detailed overview of Novartis AG's Moat Score provided by GuruFocus.com. Please click on the following links to see related term pages.

Novartis AG Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Novartis AG (MEX:NVS N) » Definitions » Moat Score

Comparable Companies

Traded in Other Exchanges

NVSEF:USA NVS:USA NOVN:Mexico 1NOVN:Italy NOVNz:UK 0K9E:UK 0QLR:UK NOT0:Germany NOTA:Germany NOT:Germany NOT:Germany NOTA:Germany NOT:Germany NOVNEE:Switzerland NOVN:Switzerland NVS:Canada N1VS34:Brazil NVS:Argentina

Address

Lichtstrasse 35, Basel, CHE, 4056

Website

https://www.novartis.com

Novartis develops and manufactures innovative drugs. Key areas of drug development include oncology, rare diseases, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States comprising close to one third of total revenue.

Novartis AG Headlines

No Headlines